| MR编号 | NL/H/5571/001 |
|---|
| 药品名称 | Doxorubicin pegylated liposomal SUN 2 mg/ml concentrate for solution for infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | Sun Pharmaceutical Industries Europe BV
Polarisavenue 87
2132 JH Hoofddorp
The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Doxorubicine gepegyleerd liposomaal SUN 2 mg/ml concentraat voor oplossing voor infusie |
|---|
| 互认成员国 - 产品名称 | - Spain (ES)
- Slovakia (SK)
- Finland (FI)
- Germany (DE)
Doxorubicin pegyliert liposomal SUN 2 mg/ml Infusionslösungskonzentrat - France (FR)
- Hungary (HU)
- Ireland (IE)
- Italy (IT)
- Norway (NO)
- Austria (AT)
- Poland (PL)
- Belgium (BE)
- Portugal (PT)
- Czechia (CZ)
Doxorubicin peg-lyposomalis SUN - Romania (RO)
Doxorubicină lipozomală polietilenglicată SUN 2 mg/ml concentrat pentru soluţie perfuzabilă - Denmark (DK)
- Sweden (SE)
- Greece (GR)
- Slovenia (SI)
|
|---|
| 许可日期 | 2023/09/13 |
|---|
| 最近更新日期 | 2024/11/19 |
|---|
| 药物ATC编码 | |
|---|
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Withdrawn（注：已撤市） |
|---|